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~Laboratoire Matd~iau~ Polym~res aua Interfaces, Universitd d'Ewy, 2Gdndthon, 
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It is lmown that polyamines, uch as polyethy lenimine (PEI), condense DNA and are able to 
favor its cellulax uptake in a variety of cells. The finear PEI (LPEI) containing only zecondax3~ 
amino ~ups ,  and branched PEI (BPEI) having primary, secondary and tertiary amine 
hmctions, were shown to be among the most efficient in viU~ transfection agents. However, 
the in viva efficiency of LPEI is better flwaa BPEI. 
The goal of flais work was to trader stand the relationship between the chemical structure of 
synthetic vector and the transfection efficiency. 
To flais end, ~ca fred LPEI (LPEI g CH z CHzNH zand LPEI g CHzCH z N(Ct~ ~) varying by 
the nature and ratio of amino ~ups ,  were synthesized in order to study the influence of the 
content of the various amine hmctions (primary, secondary nd tertiary) on the transfection 
efficiency. 
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The copolymers were first tested for their opacity to interact with plasmid DNA. All 
polymers, whatever the ratio of the various amine functions, were able to complex DNA. The 
transfecfion activity of the different polymers was tested on human hepatocarcinoma cells 
(HepG2). The results howed that he ratio of vmlous amine functions had no effect on in vitl~) 
transfecfion efficiency. Further, in vitl~) transfecfion study, using decreasing amounts of 
complex, confirmed that he transfecflon did not change with the ratio of the amino ~up s and 
show that he modified LPEI had intermediate b havior between BPEI and LPEI. 
To conclude, the results howed that he vector macro structure is a more prominent factor theal 
the relative ratio of various amine functions. Some in vivo assays were al~o achieved and 
confirmed the results obtained during the in vitl~) assays. 
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interactions in pro-inflammatory signalling 
A. Tamanini, P. Melotti, A. Bonizzato, E. Nicolis, C. Cigana, B.M. Assael, G. 
Cabrini 
Laboratory Molecular Pathology, Cystic Fibrosis Center; Azienda Ospedaliera, 
k?rona, Italy 
Different virus derived vectors such as adenovimses (Ad), adeno associated 
par voviruses (AAV) mad lentiviruses (LV) have been developed to correct CF defect 
by gene transfer into the epithelial cells of the airway tract or by re-engineering cells 
able to repopulate the lung. This study is addressed to add information on the 
pathways involved ha the early induction of the inflammatory response potentially 
associated with gene transfer vectors. We previously reported that replication 
defective Ad vectors induce the expression of the pro inf lammatory Intercellular 
Adhesion Molecule ( ICAM) 1 by early activation of Mitogen Activated Protein 
Kinases (MAPK) and the Nuclear Factor kB  (NF kB). The role of the heparan 
sulfate glycosaminoglycans (HS GAG), which are receptors uti l ized by Ad, AAV 
and LV, has been investigated. The Ad vector model has been uti l ized since it is 
fully elucidated that Ad binds to cells tbrough 3 receptors, namely HS GAGs, the 
coxsackie adenovirus receptor (CAR) and % integrin. Ad domains, namely fiber 
knob, full length fiber and c~ integrins together with extracellular receptor 
components have been tested ha A549 respir ato*3, cells. We found that the activation 
of MAPK and nuclear tr anslocation of NF kB ha the t ime lapse between 10 min to 
4 brs after binding of the Ad domains is induced by CAR but not by HS GAG or % 
integrins, thus indicating that binding to HS GAGs does not evoke these early 
signals relevant o the inflammatory response. This study provides preliminary 
evidence to build up a tbr ough testing of the biosafety aspects of novel vectors of 
the CF gene. 
Supported by I ta l ian Cystic Fibrosis Research Foundation, Legge 548/93 
Finanziamento Ricerca Fibr osi Cistica 2004. 
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Inrroduet lon:  ha developing an effective gene therapy for CF lung disease we have 
shown that pre4reatment of mouse nasal respiratory epithel ium with the detergent 
lysophosphatidycholine (LPC) enhances lentivirus (LV) mediated gene transfer in 
viva. Init ial studies howed significant gene transfer, however areas of cell damage 
were also evident. This study sought to find lower dose settings that achieved 
similar gene transfer. Methods:  For assessment of LVLacZ gene transfer a single 
dose of LPC (0.03%, 0.1%, 0.3% 1% mad 2% w/v) was instilled as a 4pl  bolus into 
the right nostril of anaesthetised C57B 1/6 mice (n 7 8 / group). One hour alter LPC 
pre treatment the LVLacZ vector (20 pl bolus, 6xl08tu/ml) was instilled. Seven 
days later mice were sacrificed and processed to reveal LacZ gene expression 
(X gal). Results :Except  the 0.03% dose of LPC all groups produced significantly 
higher gene transfer compared to control (PBS) (ANOVA, P<0.05). There was no 
significant difference in gene transfer in groups exposed to 0.3% and 1% LPC and 
gene transfer in these groups was significantly higher than ha groups exposed to 
0.1% LPC. Conclusions: Similar levels of gene transfer are produced after dosing 
with either 0.3% or 1% LPC. I f  our other studies (ha progress) confirm initial 
f indings that 0.3% LPC does not produce significant damage to epithelium, the 
lower (0.3%) dose of LPC may be a better choice in studies developing lentivir al in 
viva gene therapy ha this setting. 
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Mechanistic studies of the peptide transfection vector LAH4 
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As gene therapy is thought to be the most promising future treatment for CF 
patients, priority is given to the discovery of an adequate vector to deliver the 
treating DNA inside the defective cells. Our team is highly interested in the design 
and study of potential peptide vectors such as LAH4,  an amphipathic alpha helical 
peptide showing antibiotic properties and very low cytotoxicity. Peptides of this 
family have proven transfection capacities as efficient as existing transfection 
agents (Kichler, A. et al (2CO3) PNAS 1CO, 1564 1568). 
A high resolution NMR structure of LAH4 and two biologically active derivatives 
has already been obtained in membrane environments, these studies being ctarent ly 
expanded to test for the LAH4 interaction sites in its complex with DNA.  
Solid slate NMR,  CD spectroscopy and isothermal micrc~alorimetry studies were 
undertaken to understand the interactions between the different components of the 
transfection complex. Our ult imate goal being the conception of an atomic model of 
the mechanism based on the experimental d ta. 
Our studies have lead to the characterization f the DNA peptide binding constants, 
the stoichiometry and thermodynamic parameters at variant pH, temperatures mad 
concentrations as wel l  as the orientation and the mobility of the complex when 
bound to synthetic bilayer s. Experiments are tmderway to express the fully labeled 
LAH4 in E.coli, in order to further increase the spectral resolution of solid state 
NMR spectra and to determine hater and intramolecular distances. 
Understanding such mechanisms i a challenging task because of their complexity 
but it is a necessary step ha the design of new, more efficient agents. 
